|1.||Ebina, Takusaburo: 3 articles (05/2008 - 09/2003)|
|2.||Miki, Chikao: 2 articles (04/2008 - 01/2003)|
|3.||Yamaguchi, Kenya: 2 articles (04/2008 - 10/2005)|
|4.||Kusunoki, Masato: 2 articles (04/2008 - 01/2003)|
|5.||Hirakata, Hitoshi: 2 articles (04/2008 - 10/2005)|
|6.||Kawata, Nozomu: 2 articles (04/2008 - 10/2005)|
|7.||Tsukagoshi, Kazuhiko: 2 articles (06/2007 - 03/2005)|
|8.||Nakajima, Riichiro: 2 articles (06/2007 - 03/2005)|
|9.||Sakurai, Kenichi: 2 articles (10/2005 - 10/2004)|
|10.||Amano, Sadao: 2 articles (10/2005 - 10/2004)|
|1.||Ovarian Neoplasms (Ovarian Cancer)
12/01/1996 - "Our data suggest that immunosuppressive acidic protein assay is a potentially useful tool in the prognostic characterization of advanced ovarian cancer."
12/01/1996 - "In the univariate analysis for overall survival, International Federation of Gynecology and Obstetrics stage and immunosuppressive acidic protein status were found to have a role in predicting ovarian cancer prognosis. "
12/01/1996 - "Our purpose was to investigate immunosuppressive acidic protein in the prognostic characterization of advanced ovarian cancer. "
12/01/1996 - "Prognostic role of immunosuppressive acidic protein in advanced ovarian cancer."
09/01/1994 - "Evaluation of immunosuppressive acidic protein in human ovarian cancer."
|2.||Neoplasm Metastasis (Metastasis)
10/01/2004 - "The expression of IDO did not correlate to histological classification, growth pattern, lymphatic invasion, venous invasion, or lymph nodes metastasis, but correlated to clinicopathological stage, the value of immunosuppressive acidic protein (IAP). "
01/01/2003 - "These data show that immunosuppressive acidic protein levels may be related to lymph node metastases. "
01/01/2003 - "Significant associations among immunosuppressive acidic protein level and clinicopathological parameters, including lymphatic involvement, vascular involvement, and lymph node metastases were evident. "
12/01/1999 - "We noted no significant difference in age at diagnosis, pretreatment serum immunosuppressive acidic protein, site of metastasis or performance status in 34 patients who underwent cytoreductive surgery and 21 who did not. "
10/01/2005 - "The expression of IDO did not correlate to histologic classification, tumor size, lymphatic invasion, venous invasion and lymph nodes metastasis, but correlated to clinical stage and the serum level of immunosuppressive acidic protein (IAP). "
|3.||Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/01/1995 - "During the course of this combination therapy, study, it was found that there was a clear positive correlation between immunosuppressive acidic protein (IAP) levels and tumor sizes. "
10/01/1988 - "[A study of an immunosuppressive acidic protein (IAP) in patients with a bone tumor]."
06/01/1985 - "[Studies on immunosuppressive acidic protein (IAP) in ovarian tumors]."
10/01/2004 - "We enrolled 30 immunosuppressed patients whose immunosuppressive acidic protein (IAP) levels in serum were over 580 microg/ml, and 63 immunoreactive solid cancer outpatients whose IAP level in serum were under 580 microg/ml. Treated with BAK therapy, the mean survival time of immunosuppressed patients was 5.0 months. "
09/01/2003 - "Life-prolonging effect of immunocell BAK (BRM-activated killer) therapy for advanced solid cancer patients: prognostic significance of serum immunosuppressive acidic protein levels."
|5.||Renal Cell Carcinoma (Grawitz Tumor)
10/01/1989 - "[Study on serum levels of immunosuppressive acidic protein (IAP) as a marker of renal cell carcinoma]."
05/01/1984 - "[Study of immunosuppressive acidic protein (IAP) in patients with renal cell cancer]."
10/01/2005 - "Immunosuppressive acidic protein detects high nuclear grade localized renal cell carcinoma."
05/01/2002 - "To determine whether the immunosuppressive acidic protein (IAP) could be a useful marker for renal cell carcinoma (RCC), serum IAP levels were compared with clinicopathological features in RCC patients. "
05/01/2002 - "[Prognostic value of serum immunosuppressive acidic protein in renal cell carcinoma]."
|4.||Biological Tumor Markers (Tumor Markers)
|6.||N-Acetylneuraminic Acid (Sialic Acid)
|9.||Tissue Polypeptide Antigen
|3.||Drug Therapy (Chemotherapy)
|5.||Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)